Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)

NCT00190736 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD

Interventions

DRUG: Atomoxetine Hydrochloride
DRUG: placebo

Sponsor

Eli Lilly and Company